APAC, Infectious Diseases Diagnostics Market Segmented, by Product (Instruments, Reagents, Services, and Software), by Application (Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Tuberculosis, Chlamydia Trachomatis, Neisseria gonorrhoeae (CT/NG), Human papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue), by Technology (PCR, INAAT, DNA Sequencing, and Hybridization), and by End-User (Hospital, and Laboratories)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138332
- Pages: 200
-
Format:
Report Overview
The APAC Infectious Diseases Diagnostics Market size stood at around USD xx billion in 2019 and is projected to reach USD $42.85 billion by 2028, exhibiting a CAGR of xx% during the forecast period
Infectious diseases are the diseases which are caused by viruses, fungi and bacteria. Many of the microorganism are present in the body which are normally did no harm body but under certain condition this microorganism may led to cause different diseases
Market Drivers
Y-O-Y growth in the incidence of infectious diseases and the growing acquisition of advanced diagnostic tools in the healthcare system boost the development of the market. Mounting acquisition of advanced molecular procedures, the increasing rate of occurrence of infectious diseases like malaria, flu, and other infections, primarily sexually transmitted diseases like HIV and bacterial infections, are to boost the growth in the region. Few
government-based programs in the area offer free screening tests to increase awareness, properly diagnose diseases, and reduce the chances of infections are some factors propelling the market growth in the region
1. APAC Infectious Diseases Diagnostics Market Overview
A. Market Size
2. APAC Infectious Diseases Diagnostics Market Growth Drivers and Restraints
A. Y-O-Y growth in the incidence of infectious diseases and the growing acquisition of advanced diagnostic tools in the healthcare system
B. Increasing rate of occurrence of infectious diseases like malaria, flu, and other infections, primarily sexually transmitted diseases like HIV and bacterial infections
C. Few government-based programs in the area offer free screening tests to increase awareness, properly diagnose diseases, and reduce the chances of infections
3. APAC Infectious Diseases Diagnostics Market Segmentation
A. By Product
I. Instruments
II. Services
III. Reagents
IV. Software
B. By Application
I. Hepatitis B
II. Hepatitis C
III. Human Immunodeficiency Virus
IV. Tuberculosis
V. Chlamydia Trachomatis
VI. Neisseria gonorrhoeae (CT/NG)
VII. Human papillomavirus (HPV)
VIII. Methicillin-resistant Staphylococcus aureus (MRSA)
IX. and others (Influenza, Ebola, Typhoid, Malaria, and Dengue)
C. By Technology
I. PCR
II. INAAT
III. DNA Sequencing
IV. Hybridization
D. By End-User
I. Hospitals
II. Laboratories
4. APAC Infectious Diseases Diagnostics Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Abbott Laboratories, Company overview, Product & Services, Strategies & Financials
B. Bio Mrieux SA, Company overview, Product & Services, Strategies & Financials
C. Hologic, Inc., Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
